These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
311 related articles for article (PubMed ID: 16906777)
41. Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer. Wong SF Clin Ther; 2005 Jun; 27(6):684-94. PubMed ID: 16117976 [TBL] [Abstract][Full Text] [Related]
46. Challenges in the use of epidermal growth factor receptor inhibitors in colorectal cancer. Van Cutsem E Oncologist; 2006 Oct; 11(9):1010-7. PubMed ID: 17030643 [TBL] [Abstract][Full Text] [Related]
47. Overcoming Resistance to Anti-EGFR Therapy in Colorectal Cancer. Dienstmann R; Salazar R; Tabernero J Am Soc Clin Oncol Educ Book; 2015; ():e149-56. PubMed ID: 25993166 [TBL] [Abstract][Full Text] [Related]
48. Acquired resistance of non-small cell lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors. Nurwidya F; Takahashi F; Murakami A; Kobayashi I; Kato M; Shukuya T; Tajima K; Shimada N; Takahashi K Respir Investig; 2014 Mar; 52(2):82-91. PubMed ID: 24636263 [TBL] [Abstract][Full Text] [Related]
49. Biomarkers for predicting the efficacy of anti-epidermal growth factor receptor antibody in the treatment of colorectal cancer. Okada Y; Miyamoto H; Goji T; Takayama T Digestion; 2014; 89(1):18-23. PubMed ID: 24458108 [TBL] [Abstract][Full Text] [Related]
54. Epidermal Growth Factor Receptor (EGFR) Inhibitors and Cancer Therapeutics. Proceedings of the Radiation Therapy Oncology Group Symposium. Philadelphia, Pennsylvania, USA. June 14, 2002. Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):898-1007. PubMed ID: 14967448 [No Abstract] [Full Text] [Related]
55. Signaling mechanisms of resistance to EGFR- and Anti-Angiogenic Inhibitors cancer. Mirone G; Shukla A; Marfe G Crit Rev Oncol Hematol; 2016 Jan; 97():85-95. PubMed ID: 26364891 [TBL] [Abstract][Full Text] [Related]
56. Clinical impact of switching to a second EGFR-TKI after a severe AE related to a first EGFR-TKI in EGFR-mutated NSCLC. Takeda M; Okamoto I; Tsurutani J; Oiso N; Kawada A; Nakagawa K Jpn J Clin Oncol; 2012 Jun; 42(6):528-33. PubMed ID: 22457323 [TBL] [Abstract][Full Text] [Related]
57. Anti-epidermal growth factor receptor strategies to enhance radiation action. Lammering G Curr Med Chem Anticancer Agents; 2003 Sep; 3(5):327-33. PubMed ID: 12871078 [TBL] [Abstract][Full Text] [Related]
58. Epidermal growth factor receptor expression and gene copy number analysis in gastric carcinoma samples from Chinese patients. Zhang F; Yang X; Li L; Sun L; Wang BO; Yu X Oncol Lett; 2016 Jan; 11(1):173-181. PubMed ID: 26870185 [TBL] [Abstract][Full Text] [Related]
59. A matricellular protein and EGF-like repeat signalling in the social amoebozoan Dictyostelium discoideum. Huber RJ; O'Day DH Cell Mol Life Sci; 2012 Dec; 69(23):3989-97. PubMed ID: 22782112 [TBL] [Abstract][Full Text] [Related]
60. Epidermal growth factor receptor gene copy number in 101 advanced colorectal cancer patients treated with chemotherapy plus cetuximab. Campanella C; Mottolese M; Cianciulli A; Torsello A; Merola R; Sperduti I; Melucci E; Conti S; Diodoro MG; Zeuli M; Paoletti G; Cognetti F; Garufi C J Transl Med; 2010 Apr; 8():36. PubMed ID: 20398370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]